Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019

IMPORTANCE: Glucagonlike peptide-1 receptor agonists (GLP-1RA), sodium-glucose cotransporter-2 inhibitors (SGLT2i), and dipeptidyl peptidase-4 inhibitors (DPP-4i) are associated with low rates of hypoglycemia, and postmarketing trials of GLP-1RA and SGLT2i demonstrated that these medications improve...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Netw Open
Autori principali: McCoy, Rozalina G., Van Houten, Holly K., Deng, Yihong, Mandic, Pinar Karaca, Ross, Joseph S., Montori, Victor M., Shah, Nilay D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2021
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851726/
https://ncbi.nlm.nih.gov/pubmed/33523188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.35792
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi